Literature DB >> 2822966

Functional changes in murine macrophages infected with cytomegalovirus relate to H-2-determined sensitivity to infection.

P Price1, J G Winter, S Nikoletti, J B Hudson, G R Shellam.   

Abstract

Peritoneal macrophages were infected with murine cytomegalovirus in vitro, and indices of infection and macrophage function were monitored over 4 days. When the cells were assessed for the expression of viral antigen or for cytopathic effects, infection was found to be solely determined by the H-2 phenotype. Less than 10% of the macrophages from resistant H-2k strains were affected, whereas 90% of H-2d cells and approximately 80% of H-2b and H-2a cells became infected. Similar trends were demonstrable by the measurement of viral DNA. In H-2a cells (B10.A), Dd conferred sensitivity despite the resistant K and class II phenotype. The findings suggest a critical association between the class I antigens and an early stage in the infectious process. Indices of infection were paralleled by a loss of Fc receptor expression and optimal colloidal gold uptake, whereas most cells remained trypan blue negative, retained dehydrogenase and acid phosphatase activities, and did not release infectious virus during the period of study. This is consistent with a role for macrophages in the persistence of cytomegalovirus in the host.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822966      PMCID: PMC255961          DOI: 10.1128/JVI.61.11.3602-3606.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Cytomegalovirus infectivity: analysis of the phenomenon of centrifugal enhancement of infectivity.

Authors:  J B Hudson; V Misra; T R Mosmann
Journal:  Virology       Date:  1976-07-01       Impact factor: 3.616

Review 2.  Epidemiology and transmission of cytomegalovirus.

Authors:  R F Pass
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

3.  Phosphates of the naphthol AS series in the quantitative determination of alkaline and acid phosphatase activities "in situ" studied in polyacrylamide membrane model systems and by cytospectrophotometry.

Authors:  Z Lojda; M Van der Ploeg; P Van Duijn
Journal:  Histochemie       Date:  1967

4.  Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection.

Authors:  J E Grundy; J S Mackenzie; N F Stanley
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

5.  Nucleic acid spot hybridization: rapid quantitative screening of lymphoid cell lines for Epstein-Barr viral DNA.

Authors:  J Brandsma; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

6.  Cellular basis for susceptibility to mouse cytomegalovirus: evidence from tracheal organ culture.

Authors:  J G Nedrud; A M Collier; J S Pagano
Journal:  J Gen Virol       Date:  1979-12       Impact factor: 3.891

7.  Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance.

Authors:  G J Bancroft; G R Shellam; J E Chalmer
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

8.  Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse.

Authors:  J E Chalmer; J S Mackenzie; N F Stanley
Journal:  J Gen Virol       Date:  1977-10       Impact factor: 3.891

9.  Interspecies exchange of beta 2-microglobulin and associated MHC and differentiation antigens.

Authors:  W Schmidt; H Festenstein; P J Ward; A R Sanderson
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

Review 10.  Epidemiology of cytomegaloviral infections: recommendations for prevention and control.

Authors:  I M Onorato; D M Morens; W J Martone; S K Stansfield
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug
View more
  12 in total

1.  Inflammatory and immunological responses to murine cytomegalovirus in resistant CBA mice.

Authors:  P Price; J G Winter; K S Eddy; G R Shellam
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

2.  The BALB.B6-Cmv1r mouse: a strain congenic for Cmv1 and the NK gene complex.

Authors:  A A Scalzo; P A Lyons; N A Fitzgerald; C A Forbes; G R Shellam
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

3.  Replication of murine cytomegalovirus in mast cells.

Authors:  A E Gibbons; P Price; T A Robertson; J M Papadimitriou; G R Shellam
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  H-2 class I loci determine sensitivity to MCMV in macrophages and fibroblasts.

Authors:  P Price; A E Gibbons; G R Shellam
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

5.  Cytomegalovirus infection of adipose tissues induces steatitis in adult mice.

Authors:  P Price; K S Eddy; J M Papadimitriou; T A Robertson; G R Shellam
Journal:  Int J Exp Pathol       Date:  1990-08       Impact factor: 1.925

6.  Detection of murine cytomegalovirus DNA in circulating leukocytes harvested during acute infection of mice.

Authors:  J F Bale; M E O'Neil
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

7.  Murine cytomegalovirus interacts with major histocompatibility complex class I molecules to establish cellular infection.

Authors:  M N Wykes; G R Shellam; J McCluskey; W M Kast; P B Dallas; P Price
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections.

Authors:  M T Heise; H W Virgin
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

9.  The effects of beta-2-microglobulin on the infectivity of murine cytomegalovirus.

Authors:  M N Wykes; P Price; G R Shellam
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

10.  HIV-1 infection of monocyte-derived macrophages reduces Fc and complement receptor expression.

Authors:  S J Kent; G Stent; S Sonza; S D Hunter; S M Crowe
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.